NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

Completed

Conditions: Brugada Syndrome
Arrhythmogenic Right Ventricular Cardiomyopathy

Interventions: Drug: flecainide iv

First Posted Date: 2014-11-26

Last Posted Date: 2019-04-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 209

Registration Number: NCT02302274

Locations: 🇺🇸
New york University, School of Medicine, New York, New York, United States

Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Radiation: Radiation Therapy (RT)
Drug: Capecitabine
Drug: Trastuzumab
Drug: Paclitaxel

First Posted Date: 2014-11-21

Last Posted Date: 2018-10-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 44

Registration Number: NCT02297230

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Prospective Study of Thoracolumbar Spinal Fusion Graft

Not Applicable

Active, not recruiting

Conditions: Lumbar Degenerative Disc Disease

Interventions: Procedure: BMAC & Allograft
Procedure: Iliac Crest Bone Graft

First Posted Date: 2014-11-21

Last Posted Date: 2023-09-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 17

Registration Number: NCT02297256

Locations: 🇺🇸
NY Spine Institute, Westbury, New York, United States
🇺🇸
NYU Hospital for Joint Diseases, New York, New York, United States
🇺🇸
Center for Musculoskeletal Care (CMC), New York, New York, United States

Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization

Not Applicable

Completed

Conditions: Bladder Cancer

Interventions: Procedure: PET/MRI

First Posted Date: 2014-11-11

Last Posted Date: 2017-08-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 24

Registration Number: NCT02287701

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Investigation of the Role of Steroids in Enhancing Voice Therapy Outcomes

Phase 4

Completed

Conditions: Dysphonia

Interventions: Dietary Supplement: Lactose Pills
Drug: Steroid

First Posted Date: 2014-11-10

Last Posted Date: 2020-03-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 36

Registration Number: NCT02286960

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery

Completed

Conditions: Neuromuscular Blockade

Interventions: Drug: Rocuronium Bromide, Cisatracurium Besylate

First Posted Date: 2014-11-07

Last Posted Date: 2018-01-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 46

Registration Number: NCT02285829

Locations: 🇺🇸
NYU Langone Medical Center, Hospital for Joint Diseases, New York, New York, United States

Randomized Clinical Trial of Pneumatic Compression Device for the Treatment of Venous Ulcers and Lymphedema

Not Applicable

Terminated

Conditions: Lymphedema

Interventions: Device: Flexitouch pneumonic compression
Other: Flexitouch for 1 month in addition to routine wound care
Other: Routine wound care for venous ulcers and lymphedema

First Posted Date: 2014-11-06

Last Posted Date: 2020-03-13

Lead Sponsor: NYU Langone Health

Target Recruit Count: 39

Registration Number: NCT02284373

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Paclitaxel
Radiation: Radiation therapy

First Posted Date: 2014-10-31

Last Posted Date: 2020-11-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 69

Registration Number: NCT02280252

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Single Shot Versus OnQ Pump in Extremity Fractures

Phase 4

Completed

Conditions: Pain
Fracture

Interventions: Drug: Ankle OnQ
Drug: DR OnQ
Drug: DR SSB
Drug: Ankle SSB

First Posted Date: 2014-10-31

Last Posted Date: 2020-03-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT02280291

Locations: 🇺🇸
Hospital for Joint Diseases, New York, New York, United States

The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia

Phase 2

Completed

Conditions: Familial Dysautonomia

Interventions: Dietary Supplement: Phosphatidylserine

First Posted Date: 2014-10-28

Last Posted Date: 2021-02-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 26

Registration Number: NCT02276716

Locations: 🇺🇸
NYU Langone Medical Center, Dyautonomia Center, Suite 9Q, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy